About
Robert Discordia, Ph.D., joined Corbus in May 2018. Dr. Discordia brings to Corbus more than 25 years of biopharmaceutical industry experience in CMC development and business operations. Prior to joining the Company, Dr. Discordia was Executive Director, Business Operations and Procurement for Global Product Development & Supply at Bristol-Myers Squibb. While serving in that position, he was responsible for managing the strategic business partnerships for the company's small molecule development and commercial manufacturing. He oversaw approximately 55 employees at seven sites and $700 million in annual spend. Prior to that, he served as Bristol-Myers Squibb's Group Director & Head, External Partner Management, Pharmaceutical Development. In this capacity, he developed and led the organization, overseeing third-party providers of development services and clinical manufacturing for Bristol-Myers Squibb. Over his career, he had leadership roles in the CMC development and launch of multip
Investment Focus
- Location
- US
Contact Information
Find more investors like Robert
Search Investors